10 Best “Strong Buy” Stocks — JAZZ LCI QCOR and more

by Portfolio Grader | February 19, 2014 8:15 am

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader[1], have the best year-to-date performance.

Since January 1, Jazz Pharmaceuticals (JAZZ[2]) has climbed 29.2%. Jazz Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products to meet medical needs in neurology and psychiatry. For more information, get Portfolio Grader’s complete analysis of JAZZ stock[3].

Since January 1, Lannett Company, Inc. (LCI[4]) has jumped 29.8%. Lannett manufactures and distributes pharmaceutical products under its own trade name and under generic names. For more information, get Portfolio Grader’s complete analysis of LCI stock[5].

Questcor Pharmaceuticals, Inc. (QCOR[6]) has risen 30% since the first of the year. Questcor Pharmaceuticals develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. Trade volume rose notably over the past week, up 130.6%. For more information, get Portfolio Grader’s complete analysis of QCOR stock[7].

For more information, get Portfolio Grader’s complete analysis of YY stock[8].

Since the first of the year, shares of Tesla Motors, Inc. (TSLA[9]) have soared 38.4%. Tesla Motors designs, develops, makes and sells fully electric vehicles and components of vehicle powertrains. For more information, get Portfolio Grader’s complete analysis of TSLA stock[10].

Shares of Insys Therapeutics, Inc. (INSY[11]) have risen 38.9% since January 1. INSYS Therapeutics develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. For more information, get Portfolio Grader’s complete analysis of INSY stock[12].

The price of Ligand Pharmaceuticals Incorporated (LGND[13]) is up 39.1% since the first of the year. Ligand Pharmaceuticals develops drugs which regulate hormone activated intracellular receptors. Trade volume has increased significantly over the past week, up 310.3%. For more information, get Portfolio Grader’s complete analysis of LGND stock[14].

For more information, get Portfolio Grader’s complete analysis of ANFI stock[15].

The price of Shanda Games Ltd. Sponsored ADR Class A (GAME[16]) has seen a 50% boost since the first of the year. Shanda Games develops, sources, and operates Internet games in China. For more information, get Portfolio Grader’s complete analysis of GAME stock[17].

Since the first of the year, the price of Illumina, Inc. (ILMN[18]) has swelled 56.6%. Illumina develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. For more information, get Portfolio Grader’s complete analysis of ILMN stock[19].

Louis Navellier’s proprietary Portfolio Grader[1] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[20].

Source URL: https://investorplace.com/2014/02/10-best-strong-buy-stocks-jazz-lci-qcor-and-more-jazz-lci-qcor-yy-tsla-insy-lgnd-anfi-game-ilmn/

---